To examine the effect of RYR2 on the progression of HNSCC and OSCC, we used the Xena platform to assess the relationship between RYR2 mRNA at the cell level and patient outcomes from the HNSCC database of The Cancer Genome Atlas (TCGA). The gene discussed is RYR2; the disease is head and neck squamous cell carcinoma.